Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective.

× No keyword cloud information.

39 in total

1. Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects.

Authors: F P Alford; S R Bloom; J D Nabarro
Journal: J Clin Endocrinol Metab Date: 1976-05 Impact factor: 5.958

Review 2. The influence of drugs on nasal ciliary movement.

Authors: W A Hermens; F W Merkus
Journal: Pharm Res Date: 1987-12 Impact factor: 4.200

3. Plasma immunoreactive atrial natriuretic peptide levels after subcutaneous alpha-hANP injection in normal humans.

Authors: I G Crozier; M G Nicholls; H Ikram; E A Espiner; T G Yandle
Journal: J Cardiovasc Pharmacol Date: 1987-07 Impact factor: 3.105

4. Bioavailability of nasally administered progesterone.

Authors: J F Steege; S L Rupp; A L Stout; M Bernhisel
Journal: Fertil Steril Date: 1986-10 Impact factor: 7.329

5. Intranasal absorption of salmon calcitonin.

Authors: H Kurose; Y Seino; M Shima; H Tanaka; M Ishida; K Yamaoka; H Yabuuchi
Journal: Calcif Tissue Int Date: 1987-11 Impact factor: 4.333

6. The effect of rectal and nasal administration of salmon calcitonin in normal subjects.

Authors: T Buclin; J P Randin; A F Jacquet; M Azria; M Attinger; F Gomez; P Burckhardt
Journal: Calcif Tissue Int Date: 1987-11 Impact factor: 4.333

7. Nasal absorption of natural contraceptive steroids in rats-progesterone absorption.

Authors: A A Hussain; S Hirai; R Bawarshi
Journal: J Pharm Sci Date: 1981-04 Impact factor: 3.534

8. Nasal absorption of propranolol in humans.

Authors: A Hussain; T Foster; S Hirai; T Kashihara; R Batenhorst; M Jones
Journal: J Pharm Sci Date: 1980-10 Impact factor: 3.534

9. Effect of intranasal growth hormone-releasing hormone and corticotropin-releasing hormone administration on growth hormone and cortisol release: improved bioavailability by means of sodium-glycocholate.

Authors: A E Pontiroli; M G Perfetti; B Fattor; G Pozza
Journal: J Clin Endocrinol Metab Date: 1989-04 Impact factor: 5.958

10. Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects.

Authors: A C Moses; G S Gordon; M C Carey; J S Flier
Journal: Diabetes Date: 1983-11 Impact factor: 9.461

12 in total

1. Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump.

Authors: J D Suman; B L Laube; R Dalby
Journal: Pharm Res Date: 1999-10 Impact factor: 4.200

2. Multiple-dose pharmacokinetics of intranasally administered IS-159 in healthy subjects.

Authors: Paul L M Van Giersbergen; Jasper Dingemanse
Journal: Eur J Drug Metab Pharmacokinet Date: 2003 Jan-Mar Impact factor: 2.441

3. Rapid reconstitution packages (RRPs) for stable storage and delivery of glucagon.

Authors: Sebastian D'hers; Agustín N Abad Vazquez; Pablo Gurman; Noel M Elman
Journal: Drug Deliv Transl Res Date: 2019-06 Impact factor: 4.617

4. Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects.

Authors: T Kissel; J Drewe; S Bantle; A Rummelt; C Beglinger
Journal: Pharm Res Date: 1992-01 Impact factor: 4.200

5. The hypotonic effect of intranasal and intravenous glucagon in gastrointestinal radiology.

Authors: M Pacchioni; C Orena; P Panizza; E Cucchi; A Del Maschio; A E Pontiroli
Journal: Abdom Imaging Date: 1995 Jan-Feb

Review 6. Intranasal glucagon: a promising approach for treatment of severe hypoglycemia.

Authors: Antonio E Pontiroli
Journal: J Diabetes Sci Technol Date: 2014-11-10

7. Relative bioavailability of nicotine from a nasal spray in infectious rhinitis and after use of a topical decongestant.

Authors: E Lunell; L Molander; M Andersson
Journal: Eur J Clin Pharmacol Date: 1995 Impact factor: 2.953

8. Carbopol-based gels for nasal delivery of progesterone.

Authors: Grace Rathnam; N Narayanan; R Ilavarasan
Journal: AAPS PharmSciTech Date: 2008-10-11 Impact factor: 3.246

9. Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.

Authors: N G Schipper; J C Verhoef; L M De Lannoy; S G Romeijn; J H Brakkee; V M Wiegant; W H Gispen; F W Merkus
Journal: Br J Pharmacol Date: 1993-12 Impact factor: 8.739

10. Lack of effect of ammonium glycyrrhizinate on the morphology of ovine nasal mucosa in vitro.

Authors: P M Reardon; D A Wall; T K Hart; P L Smith; C H Gochoco
Journal: Pharm Res Date: 1993-09 Impact factor: 4.200